Renaissance Technologies’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Sell |
38,200
-52,400
| -58% | -$718K | ﹤0.01% | 2803 |
|
|
2025
Q1 | $1M | Sell |
90,600
-47,600
| -34% | -$526K | ﹤0.01% | 2432 |
|
|
2024
Q4 | $1.47M | Buy |
+138,200
| New | +$1.47M | ﹤0.01% | 2255 |
|
|
2024
Q1 | – | Sell |
-91,300
| Closed | -$1.37M | – | 4103 |
|
|
2023
Q4 | $1.37M | Sell |
91,300
-69,000
| -43% | -$1.04M | ﹤0.01% | 2200 |
|
|
2023
Q3 | $2.25M | Buy |
160,300
+86,300
| +117% | +$1.21M | ﹤0.01% | 1788 |
|
|
2023
Q2 | $766K | Buy |
74,000
+26,000
| +54% | +$269K | ﹤0.01% | 2635 |
|
|
2023
Q1 | $444K | Buy |
48,000
+4,700
| +11% | +$43.5K | ﹤0.01% | 2943 |
|
|
2022
Q4 | $384K | Buy |
43,300
+200
| +0.5% | +$1.77K | ﹤0.01% | 3105 |
|
|
2022
Q3 | $359K | Sell |
43,100
-500
| -1% | -$4.17K | ﹤0.01% | 3115 |
|
|
2022
Q2 | $357K | Buy |
43,600
+18,900
| +77% | +$155K | ﹤0.01% | 3354 |
|
|
2022
Q1 | $215K | Buy |
+24,700
| New | +$215K | ﹤0.01% | 3614 |
|
|
2021
Q1 | – | Sell |
-32,800
| Closed | -$591K | – | 3728 |
|
|
2020
Q4 | $591K | Buy |
+32,800
| New | +$591K | ﹤0.01% | 2745 |
|
|
2019
Q2 | – | Sell |
-8,000
| Closed | -$296K | – | 3767 |
|
|
2019
Q1 | $296K | Buy |
+8,000
| New | +$296K | ﹤0.01% | 3098 |
|
|
2018
Q4 | – | Sell |
-16,800
| Closed | -$793K | – | 3629 |
|
|
2018
Q3 | $793K | Sell |
16,800
-98,651
| -85% | -$4.66M | ﹤0.01% | 2697 |
|
|
2018
Q2 | $5.75M | Sell |
115,451
-41,249
| -26% | -$2.05M | 0.01% | 1699 |
|
|
2018
Q1 | $7.79M | Buy |
156,700
+25,600
| +20% | +$1.27M | 0.01% | 1530 |
|
|
2017
Q4 | $4.88M | Buy |
131,100
+105,500
| +412% | +$3.93M | 0.01% | 1824 |
|
|
2017
Q3 | $807K | Buy |
+25,600
| New | +$807K | ﹤0.01% | 2645 |
|